24 Results for "

3C-like

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "3C-like" in MCE Product Catalog:

111
111 Publications Verification
Cat. No.: HY-138687
CAS No.: 2628280-40-8
Purity:  99.74%
Synonyms: PF-07321332
Target:  

SARS-CoV

Research Areas:  

Infection Inflammation/Immunology

Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-137048
CAS No.: 870153-29-0
Purity:  99.31%
Target:  

SARS-CoV HIV HCV

Research Areas:  

Infection

PF-00835231 is a CoV-2 cysteine 3C-like protease (3CL pro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CL pro, respectively. PF-00835231 is developed for the research of anti-SARS-CoV-2/COVID-19. PF-00835231 can inhibit cell infections and also suppress infections in animal models [3].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100943
CAS No.: 54-84-2
Purity:  99.48%
Synonyms: SQ 10643
Cinanserin hydrochloride (SQ 10643) is a potent, selective and highly affinity 5-HT2 receptor antagonist with a Ki of 41 nM. Cinanserin hydrochloride has a much higher binding affinity for the 5-HT2 than for the 5-HT1 receptor (Ki of 3500 nM). Cinanserin is also an inhibitor of 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro [3].
loading...
    loading...
Cat. No.: HY-172437
CAS No.: 2996148-73-1
Synonyms: S-892216
Target:  

Virus Protease SARS-CoV

Research Areas:  

Infection

Secutrelvir is an oral SARS-CoV-2 3C-like protease (3CLpro) inhibitor and antiviral agent, with IC50 values of 0.655 nM and 0.697 nM against SARS-CoV-2 3CLpro, respectively. Secutrelvir forms a reversible covalent bond with the catalytic cysteine C145 of SARS-CoV-2 3CLpro, thereby inhibiting viral replication. Secutrelvir exhibits activity against multiple SARS-CoV-2 variants and can be used in research related to coronavirus disease 2019 (COVID-19) [3].
loading...
    loading...
Cat. No.: HY-156651
CAS No.: 2773516-53-1
Purity:  99.71%
Synonyms: EDP-235
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

Zevotrelvir (EDP-235) is a coronavirus inhibitor that can inhibit 229E hCoV and the SARS-CoV-2 3C-like (3CL) protease (IC50 <0.1 mM). Zevotrelvir can be used in research on coronavirus infections .
loading...
    loading...
Cat. No.: HY-P3794
CAS No.: 198551-00-7
Target:  

Virus Protease

Research Areas:  

Infection

Glu-Ala-Leu-Phe-Gln-pNA is a Chiba virus 3C-like protease (CVP) substrate .
loading...
    loading...
Cat. No.: HY-177910
CAS No.: 75445-60-2
Target:  

SARS-CoV

Research Areas:  

Infection

Anticoronavirus agent-1 (Compound IV-2) is a 1,4-naphthone compound and is a 3CL hydrolase inhibitor (3C-like proteinase) of the 19-nCoV novel coronavirus. Anticoronavirus agent-1 has low cytotoxity on HSF cells. Anticoronavirus agent-1 can be used for the study of the novel coronavirus .
loading...
    loading...
Cat. No.: HY-138687R
CAS No.: 2628280-40-8
Synonyms: PF-07321332 (Standard)
Nirmatrelvir (Standard) is the analytical standard of Nirmatrelvir. This product is intended for research and analytical applications. Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-145435
CAS No.: 2721455-52-1
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-12 (Compound 27) is a potent SARS-CoV-2-related 3C-like protease inhibitor (Ki=32.1 pM) for preventing SARS-CoV-2 viral replication and that could be useful in the research of COVID-19 .
loading...
    loading...
Cat. No.: HY-143470
CAS No.: 184904-82-3
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-18 (Compound 26) is a potent SARS-CoV-2 3C-like protease inhibitor with an IC50 of 45 nM .
loading...
    loading...
Cat. No.: HY-151535
CAS No.: 2913186-57-7
Target:  

SARS-CoV

Research Areas:  

Infection Inflammation/Immunology

SARS-CoV-2 3CLpro-IN-5 is a covalent inhibitor of 3C-like protease (3CL pro). SARS-CoV-2 3CLpro-IN-5 has inhibitory activity for 3CL pro with an IC50 value of 3.8 nM. SARS-CoV-2 3CLpro-IN-5 has 9.0% oral bioavailability (BA). SARS-CoV-2 3CLpro-IN-5 can be used for the research of coronavirus disease 2019 (COVID-19) .
loading...
    loading...
Cat. No.: HY-138687S1
CAS No.: 2861202-75-5
Synonyms: PF-07321332-d6
Nirmatrelvir-d6 (PF-07321332-d6) is deuterium labeled Nirmatrelvir. Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
loading...
    loading...
Cat. No.: HY-145276
CAS No.: 2722634-95-7
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-10 is a potent and nontoxic inhibitor of SARS-CoV-2 3CL protease (3CLpro) with an IC50 and EC50 of 0.13 and 1.03 nM, respectively. SARS-CoV-2 3C-like protease (3CLpro), an enzyme essential for viral replication, is an attractive target for intervention. SARS-CoV-2-IN-11 may lead to the emergence of effective SARS-CoV-2-specific antivirals .
loading...
    loading...
Cat. No.: HY-145277
CAS No.: 2722635-28-9
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-11 is a potent and nontoxic inhibitor of SARS-CoV-2 3CL protease (3CLpro) with an IC50 and EC50 of 0.17 and 1.45 nM, respectively. SARS-CoV-2 3C-like protease (3CLpro), an enzyme essential for viral replication, is an attractive target for intervention. SARS-CoV-2-IN-11 may lead to the emergence of effective SARS-CoV-2-specific antivirals .
loading...
    loading...
Cat. No.: HY-P7429
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: M Proteinase; 3CL Proteinase; 2019-nCoV 3C-like Proteinase
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P7429A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: M Proteinase; 3CL Proteinase; 2019-nCoV 3C-like Proteinase
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-160594
CAS No.: 890648-80-3
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

SARS 3CLpro-IN-2 (Example 9) is a severe acute respiratory syndrome 3C-like protease (SARS 3CL pro) inhibitor with an IC50 of 0.02 mM. It exhibits antiviral activity against SARS with an EC50 of 42 mM. SARS 3CLpro-IN-2 can be used in research related to severe acute respiratory syndrome .
loading...
    loading...
Cat. No.: HY-100943R
CAS No.: 54-84-2
Synonyms: SQ 10643 (Standard)
Cinanserin (hydrochloride) (Standard) is the analytical standard of Cinanserin (hydrochloride) (HY-100943). This product is intended for research and analytical applications. Cinanserin hydrochloride (SQ 10643) is a potent, selective and highly affinity 5-HT2 receptor antagonist with a Ki of 41 nM. Cinanserin hydrochloride has a much higher binding affinity for the 5-HT2 than for the 5-HT1 receptor (Ki of 3500 nM). Cinanserin is also an inhibitor of 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro [3].
loading...
    loading...
Cat. No.: HY-P78275
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: 3C-like protease; 3CL Protease; 3CL-Mpro; 3CL Pro; COVID-19; M Proteinase; Mpro
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-183752
CAS No.: 3069291-10-4
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

CG-0988 is a selective SARS-CoV-2 3C-like protease (3CL pro) inhibitor with an IC50 of 8.5 nM. CG-0988 functionally inhibits SARS-CoV-2 3CL pro, blocks SARS-CoV-2 replication, and exerts antiviral activity against SARS-CoV-2 variants. CG-0988 can be used in research related to coronavirus disease 2019 (COVID-19) .
loading...
    loading...